Real-time enrollment status for this alpha-1 antitrypsin deficiency (aatd) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:55 PM UTC
| NCT Number | NCT07227207 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency (AATD) |
| Phase | Clinical Trial |
| Target Enrollment | 72 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Tessera Therapeutics, Inc. |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 13, 2026: Clinical trial NCT07227207 is currently recruiting participants. This clinical trial study for alpha-1 antitrypsin deficiency (aatd) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Tessera Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227207 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227207 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.